Latest AI and machine learning research in brain cancer for healthcare professionals.
CNS cancers are complex, difficult-to-treat malignancies that remain insufficiently understood and m...
INTRODUCTION: Artificial intelligence (AI) has been growing in the field of medical imaging and clin...
The current standard-of-care (SOC) practice for defining the clinical target volume (CTV) for radiat...
This study investigated the effects of feature augmentation, which uses generated images with specif...
The mortality rates have been increasing for glioma in adolescents and young adults (AYAs, aged 15-3...
Epigenetic mechanisms play a crucial role in driving transcript expression and shaping the phenotypi...
INTRODUCTION: Glioblastoma (GBM) is the most malignant primary brain cancer, associated with a media...
Differentiating pseudoprogression (PsP) from true progression (TP) in high-grade glioma (HGG) patien...
This study aimed to explore whether an artificial intelligence iterative reconstruction (AIIR) algor...
Brain tumors are a significant challenge to human health as they impair the proper functioning of th...
This review provides a comprehensive overview of current practices and recent advancements in the di...
This paper presents a novel transfer learning approach for segmenting brain tumors in Magnetic Reson...
BACKGROUND: In the German medical billing system, surgical departments encode their procedures in OP...
Clinical drivers for real-time head and neck (H&N) tumor tracking during radiation therapy (RT) are ...
BACKGROUND: This study aimed to develop and validate a multi-temporal magnetic resonance imaging (MR...
OBJECTIVES: Radiation-induced xerostomia is a common sequela in patients who undergo head and neck r...
Glioblastoma multiforme (GBM) is the most aggressive type of brain cancer, making effective treatmen...
Brain tumors (BT) can cause fatal outcomes by affecting body functions, making precise early detecti...
Accurate prediction of skeletal changes during orthodontic treatment in growing patients remains cha...
Assessing MGMT promoter methylation is crucial for determining appropriate glioblastoma therapy. Pre...
PURPOSE: To predict the 1p/19q molecular status of Lower-grade glioma (LGG) patients nondestructivel...